Experimentally induced lysosomal dysfunction disrupts processing of hypothalamic releasing factors

Area of Science:

• Neuroscience
• Cell Biology
• Aging Research

Background:

• Experimentally induced lysosomal dysfunction mimics aging features in the brain's cortex.
• The hypothalamus plays a critical role in aging and hormone regulation.

Purpose of the Study:

• To investigate if lysosomal dysfunction induces aging-like changes in the hypothalamus.
• To determine if lysosomal dysfunction affects the processing of key hypothalamic releasing factors.

Main Methods:

• Cultured hypothalamic slices were exposed to N-CBZ-L-phenylalanyl-L-alanine-diazomethylketone (ZPAD), a cathepsin inhibitor.
• Lysosome proliferation, endosome-lysosome spread, and meganeuriite formation were assessed.
• Levels and axonal transport of growth hormone releasing hormone (GHRH) and somatostatin were analyzed.

Main Results:

• ZPAD increased lysosome numbers and caused endosome-lysosome spread into dendrites and meganeuriites in specific hypothalamic nuclei.
• The arcuate nucleus showed resistance to ZPAD-induced lysosomal changes.
• Axonal transport of GHRH was impaired, with peptide accumulation in puncta, suggesting transport failure.

Conclusions:

• Lysosomal dysfunction differentially affects hypothalamic regions, with the arcuate nucleus showing unique resistance.
• Lysosomal dysfunction disrupts the axonal transport of hypothalamic releasing factors, impacting neuroendocrine function.
• These findings have implications for understanding endocrine senescence and age-related changes in the hypothalamus.